Pfizer CEO Albert Bourla is expected at a pro-Trump fundraiser on Friday, sources told CBS News, one day after the president sent a letter pushing drug companies to slash prices.

| June 9, 2025, at 8:33 a.m. More ... Reuters FILE PHOTO: Pfizer logo is seen in this illustration taken, May 1, 2022. REUTERS/Dado Ruvic/Illustration By Michael Erman ...

We estimate Pfizer’s valuation to be $32 per share, reflecting a solid nearly 40% upside. At its current price of $23, Pfizer stock trades at just 8 times trailing earnings of $2.91 per share.

While Pfizer CEO Albert Bourla, Ph.D., said he couldn’t reveal many details, he noted that Pfizer is in “very active discussions” around most favored nation drug pricing.

Trump is pushing drug companies to lower their prices, but experts cast doubt on how effective this endeavor will prove.

Pfizer Inc. (NYSE:PFE) is one of the best wide moat stocks to buy now. On June 9, Pfizer, along with other drug manufacturers, had a meeting with the Trump administration to talk about reducing US ...

Despite rolling back price increases earlier this year, Pfizer CEO Ian Read said the drugmaker will likely go back to "business as normal" for drug price hikes come January, according to MarketWatch.

President Donald Trump said his administration would “deploy every tool” to get drug prices reduced from large pharmaceutical companies if they do not meet the deadline.

Pfizer and other drug companies have met with the Trump administration to discuss lowering U.S. drug prices but no commitments have been made, Chief Executive Albert Bourla said on Monday.